|Bid||90.28 x 500|
|Ask||90.29 x 100|
|Day's range||89.00 - 90.74|
|52-week range||81.18 - 92.00|
|PE ratio (TTM)||16.62|
|Dividend & yield||2.76 (3.09%)|
|1y target est||N/A|
Procter & Gamble Co. sparred with activist investor Nelson Peltz on Thursday, with the two sides debating whether the company’s latest results prove a turnaround is taking hold.
Procter & Gamble Co, which is under pressure from activist investor Nelson Peltz, reported another quarter of market-beating profit, helped by cost-cutting, and forecast a full-year profit that topped estimates. P&G's report comes amid rising pressure from investors, including Peltz, to prop up its stock price and sales, which have lagged those of peers such as Unilever Plc. While P&G's organic sales rose 2 percent in the latest quarter, Unilever's increased 3 percent in the same period.
Consumer products giant Procter & Gamble -- which counts Gillette among its products -- said fiscal fourth quarter profit was $2.2 billion, up 13.5 percent